A wave of major financings and collaborations on February 25 signals renewed investor confidence in biotech, with giants …
A wave of major financings and collaborations on February 25 signals renewed investor confidence in biotech, with giants …
A landmark multi-hundred million dollar collaboration between Takeda and BridGene Biosciences redefines biotech funding trends this week, joined …
February 2025 sees a surge in large-scale biotech investments—from Eikon’s massive Series D to critical autoimmune and oncology …
Innovation, investment, and ideals intersected dramatically at the AI Action Summit—held 10–11 February at Paris’s Grand Palais. Co-chaired …
The 26th Clinical Trial Supply Europe conference (25–26 February, Barcelona) will showcase how AI, logistics innovation, and regulatory …
A new survey finds that over 80% of healthcare professionals notice sex-related differences in disease progression and treatment …
Multiple clinical-stage biotechs unveil bold 2025 roadmaps—from Denali’s upcoming BLA for Hunter syndrome to Cabaletta’s expanding autoimmune cell …
Bio‑Path outlines a robust development and regulatory path ahead, aiming to advance both cancer and obesity-focused therapies using …
The 43rd annual J.P. Morgan Healthcare Conference begins in San Francisco under tighter security and market uncertainty, but …
A three-year collaboration between Vertex and Orna Therapeutics brings cutting-edge lipid nanoparticle delivery into the spotlight, aiming to …
Already a subscriber? Log in